I

Innolake Biopharm

5 employees

Innolake Biopharm clinical-stage biotech company with a focus on oncology and autoimmune disease areas.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
autoimmune
Therapeutics
Oncology
Medical
biotech

Date founded

2020

Funding rounds raised

Total raised

$46M

from 4 investors over 4 rounds

I

Innolake Biopharm raised $14M on June 5, 2023

Investors: WuXi Biologics

I

Innolake Biopharm raised $46M on January 1, 2021

Investors: 华盖资本有限责任公司, WuXi Biologics and CDH Investments

FAQ